Phase 2 Study of Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Trastuzumab; Vinorelbine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 28 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 May 2008 New trial record.